Attached files
| file | filename |
|---|---|
| EX-3.2 - EXHIBIT 3.2 - Rasna Therapeutics Inc. | a03312017rasnaexhibit32.htm |
| EX-32.2 - EXHIBIT 32.2 - Rasna Therapeutics Inc. | a03312017rasnaexhibit322.htm |
| EX-32.1 - EXHIBIT 32.1 - Rasna Therapeutics Inc. | a03312017rasnaexhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - Rasna Therapeutics Inc. | a03312017rasnaexhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Rasna Therapeutics Inc. | a03312017rasnaexhibit311.htm |
| EX-14 - EXHIBIT 14 - Rasna Therapeutics Inc. | a03312017rasnaexhibit14.htm |
| 10-K - 10-K - Rasna Therapeutics Inc. | a033117rasna10-kproject.htm |
Exhibit 21
Rasna Research, Inc., a Delaware corporation
Exhibit 24
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, Kunwar Shailubhai, his attorney-in-fact, each with full power of substitution and resubstitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature | Title(s) | Date | ||
Kunwar Shailubhai | Director, Chief Executive Officer | June 29, 2017 | ||
(Principal Executive Officer) | ||||
Tiziano Lazzaretti | Chief Financial Officer | June 29, 2017 | ||
(Principal Accounting and Financial Officer) | ||||
Riccardo Dalla-Favera | Director | June 29, 2017 | ||
Jim Mervis | Director | June 29, 2017 | ||
John Brancaccio | Director | June 29, 2017 | ||
Alessandro Padova | Director | June 29, 2017 | ||
John Alex Martin | Director | June 29, 2017 | ||
Jim Tripp | Director | June 29, 2017 | ||